Lexicon Pharmaceuticals | LXRX - Ebitda





Ebitda Alterar Data
Abbott USD 2.43B 844M 2026-03
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 9.46B 3.54B 2026-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Illumina USD 330M 80M 2026-06
Insmed USD -80.97M 93.7M 2026-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 8.99B 721M 2026-06
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD -64.54M 34.34M 2026-06
MannKind USD 2.47M 461K 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -687M 571M 2026-06
Novartis USD 8.62B 2.14B 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Thermo Fisher Scientific USD 3.79B 244M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
United Therapeutics USD 334.2M 20.8M 2026-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12